These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19288194)

  • 21. Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2007; 25(12):1007-29. PubMed ID: 18047387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of anti-fibrinolytics, rFVIIa and other pro-coagulants: prophylactic versus rescue?
    Shah NL; Caldwell SH; Berg CL
    Clin Liver Dis; 2009 Feb; 13(1):87-93. PubMed ID: 19150313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
    Bauzá G; Hirsch E; Burke P; Quillen K
    Transfusion; 2007 Apr; 47(4):749-51. PubMed ID: 17381636
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of new procoagulants in blunt and penetrating trauma.
    Peralta MR; Chowdary P
    Curr Opin Anaesthesiol; 2019 Apr; 32(2):200-205. PubMed ID: 30817396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal strategies and outcomes in patients with atrial fibrillation and warfarin-associated intracranial hemorrhage.
    Singer DE; Borowsky LH; Regan S; Lee JW; Zint K; Franca LR; Goldstein JN
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104903. PubMed ID: 32689580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
    Tomita E; Takase H; Tajima K; Suematsu Y
    Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
    Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
    Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant factor VIIa as haemostatic therapy in advanced liver disease.
    Mannucci PM; Franchini M
    Blood Transfus; 2013 Oct; 11(4):487-90. PubMed ID: 23114524
    [No Abstract]   [Full Text] [Related]  

  • 30. Exploratory study on the reversal of warfarin with rFVIIa in healthy subjects.
    Skolnick BE; Mathews DR; Khutoryansky NM; Pusateri AE; Carr ME
    Blood; 2010 Aug; 116(5):693-701. PubMed ID: 20385794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant factor VIIa for warfarin-associated intracranial bleeding.
    Ilyas C; Beyer GM; Dutton RP; Scalea TM; Hess JR
    J Clin Anesth; 2008 Jun; 20(4):276-9. PubMed ID: 18617125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study.
    Bernstein DE; Jeffers L; Erhardtsen E; Reddy KR; Glazer S; Squiban P; Bech R; Hedner U; Schiff ER
    Gastroenterology; 1997 Dec; 113(6):1930-7. PubMed ID: 9394733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant.
    Tobias JD; Berkenbosch JW; Russo P
    Pediatr Crit Care Med; 2003 Jan; 4(1):49-51. PubMed ID: 12656542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plugged-percutaneous liver biopsy in patients with impaired coagulation and ascites.
    Kamphuisen PW; Wiersma TG; Mulder CJ; de Vries RA
    Pathophysiol Haemost Thromb; 2002; 32(4):190-3. PubMed ID: 12759521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of recombinant factor VIIa in trauma patients.
    Talbot M; Tien HC
    J Am Acad Orthop Surg; 2009 Aug; 17(8):477-81. PubMed ID: 19652029
    [No Abstract]   [Full Text] [Related]  

  • 37. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Manning BJ; Hynes N; Courtney DF; Sultan S
    Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):525-7. PubMed ID: 16099693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
    Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
    Cochrane Database Syst Rev; 2012 Mar; (3):CD005011. PubMed ID: 22419303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.
    Shirahata A; Fukutake K; Takamatsu J; Shima M; Hanabusa H; Mugishima H; Amano K; Takedani H; Tamashima S; Matsushita T; Tawa A; Tanaka I; Higasa S; Kosaka Y; Fujii T; Sakai M; Migita M; Kawakami K; Ohashi Y; Saito H
    Haemophilia; 2013 Nov; 19(6):853-60. PubMed ID: 23738888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant factor VIIa improves coagulopathy caused by liver failure.
    Brown JB; Emerick KM; Brown DL; Whitington PF; Alonso EM
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):268-72. PubMed ID: 12960648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.